Post by Novartis

As #EAACI2026 gets underway, Novartis is advancing bold science to reimagine what’s possible in Immunology. Immune mediated diseases are complex, progressive and often deeply life limiting. In chronic inducible urticaria, symptoms can significantly disrupt daily life, yet unmet need remains. Our commitment to lead in science and innovation is driven by one goal: bringing relief and renewed hope to patients. 📍 Follow our journey at European Academy of Allergy and Clinical Immunology - EAACI